Catalyst Wire Dossier Catalyst Wire Dossier

DAA-based therapy

direct-acting antiviral therapy for hepatitis C
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DAA-based therapy, covering 2016-10-17 to 2016-10-17. Get the full timeline:

Most recent: Clinical Trial Update: Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

See pricing